WO2008148967A3 - Preparations pharmaceutiques ou cosmetiques pour application topique et/ou parenterale, leurs procedes de preparation, et leurs utilisations - Google Patents
Preparations pharmaceutiques ou cosmetiques pour application topique et/ou parenterale, leurs procedes de preparation, et leurs utilisations Download PDFInfo
- Publication number
- WO2008148967A3 WO2008148967A3 PCT/FR2008/050728 FR2008050728W WO2008148967A3 WO 2008148967 A3 WO2008148967 A3 WO 2008148967A3 FR 2008050728 W FR2008050728 W FR 2008050728W WO 2008148967 A3 WO2008148967 A3 WO 2008148967A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- topical
- pharmaceutical
- parenteral application
- same
- preparation methods
- Prior art date
Links
- 239000002537 cosmetic Substances 0.000 title abstract 2
- 230000000699 topical effect Effects 0.000 title abstract 2
- 238000002360 preparation method Methods 0.000 title 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 238000002316 cosmetic surgery Methods 0.000 abstract 1
- 125000000600 disaccharide group Chemical group 0.000 abstract 1
- 229920002674 hyaluronan Polymers 0.000 abstract 1
- 229960003160 hyaluronic acid Drugs 0.000 abstract 1
- 150000004492 retinoid derivatives Chemical class 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/07—Retinol compounds, e.g. vitamin A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/203—Retinoic acids ; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7016—Disaccharides, e.g. lactose, lactulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/728—Hyaluronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/347—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Birds (AREA)
- Dermatology (AREA)
- Molecular Biology (AREA)
- Emergency Medicine (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
L'invention concerne une composition pharmaceutique ou cosmétique pour application topique et/ou parentérale comprenant, dans un milieu physiologiquement acceptable, au moins un rétinoïde ou ses sels et dérivés, et au moins un oligomère d'acide hyaluronique choisi parmi les composés contenant de 1 à 6 unités disaccharidiques. L'invention s'applique en particulier en dermatologie humaine ou en chirurgie réparatrice.
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP08805683A EP2155149A2 (fr) | 2007-05-11 | 2008-04-22 | Preparations pharmaceutiques ou cosmetiques pour application topique et/ou parenterale, leurs procedes de preparation, et leurs utilisations |
CA002686558A CA2686558A1 (fr) | 2007-05-11 | 2008-04-22 | Preparations pharmaceutiques ou cosmetiques pour application topique et/ou parenterale, leurs procedes de preparation, et leurs utilisations |
US12/599,510 US20100298259A1 (en) | 2007-05-11 | 2008-04-22 | Pharmaceutical or cosmetic preparations for topical and/or parenteral application, preparation methods thereof and use of same |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0755034 | 2007-05-11 | ||
FR0755034 | 2007-05-11 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2008148967A2 WO2008148967A2 (fr) | 2008-12-11 |
WO2008148967A3 true WO2008148967A3 (fr) | 2009-02-19 |
Family
ID=38828706
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/FR2008/050728 WO2008148967A2 (fr) | 2007-05-11 | 2008-04-22 | Preparations pharmaceutiques ou cosmetiques pour application topique et/ou parenterale, leurs procedes de preparation, et leurs utilisations |
Country Status (4)
Country | Link |
---|---|
US (1) | US20100298259A1 (fr) |
EP (1) | EP2155149A2 (fr) |
CA (1) | CA2686558A1 (fr) |
WO (1) | WO2008148967A2 (fr) |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8691279B2 (en) | 2010-03-22 | 2014-04-08 | Allergan, Inc. | Polysaccharide and protein-polysaccharide cross-linked hydrogels for soft tissue augmentation |
US8853184B2 (en) | 2007-11-30 | 2014-10-07 | Allergan, Inc. | Polysaccharide gel formulation having increased longevity |
US8921338B2 (en) | 2010-03-12 | 2014-12-30 | Allergan Industrie, Sas | Fluid compositions for improving skin conditions |
US9114188B2 (en) | 2010-01-13 | 2015-08-25 | Allergan, Industrie, S.A.S. | Stable hydrogel compositions including additives |
US9228027B2 (en) | 2008-09-02 | 2016-01-05 | Allergan Holdings France S.A.S. | Threads of Hyaluronic acid and/or derivatives thereof, methods of making thereof and uses thereof |
US9238013B2 (en) | 2008-08-04 | 2016-01-19 | Allergan Industrie, Sas | Hyaluronic acid-based gels including lidocaine |
US9265761B2 (en) | 2007-11-16 | 2016-02-23 | Allergan, Inc. | Compositions and methods for treating purpura |
US9333160B2 (en) | 2010-01-13 | 2016-05-10 | Allergan Industrie, Sas | Heat stable hyaluronic acid compositions for dermatological use |
US9393263B2 (en) | 2011-06-03 | 2016-07-19 | Allergan, Inc. | Dermal filler compositions including antioxidants |
US9408797B2 (en) | 2011-06-03 | 2016-08-09 | Allergan, Inc. | Dermal filler compositions for fine line treatment |
US11844878B2 (en) | 2011-09-06 | 2023-12-19 | Allergan, Inc. | Crosslinked hyaluronic acid-collagen gels for improving tissue graft viability and soft tissue augmentation |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2861734B1 (fr) | 2003-04-10 | 2006-04-14 | Corneal Ind | Reticulation de polysaccharides de faible et forte masse moleculaire; preparation d'hydrogels monophasiques injectables; polysaccharides et hydrogels obtenus |
US8883139B2 (en) | 2010-08-19 | 2014-11-11 | Allergan Inc. | Compositions and soft tissue replacement methods |
US8889123B2 (en) | 2010-08-19 | 2014-11-18 | Allergan, Inc. | Compositions and soft tissue replacement methods |
US9005605B2 (en) | 2010-08-19 | 2015-04-14 | Allergan, Inc. | Compositions and soft tissue replacement methods |
US20130096081A1 (en) | 2011-06-03 | 2013-04-18 | Allergan, Inc. | Dermal filler compositions |
RU2740454C2 (ru) | 2011-06-03 | 2021-01-14 | Аллерган Эндюстри, Сас | Составы кожного наполнителя, включая антиоксиданты |
US20130244943A1 (en) | 2011-09-06 | 2013-09-19 | Allergan, Inc. | Hyaluronic acid-collagen matrices for dermal filling and volumizing applications |
ITMI20120027A1 (it) * | 2012-01-12 | 2013-07-13 | New Yemaya Internat Srl | Composizione cosmetica avente azione rivitalizzante sull'epidermide |
EP3620184A1 (fr) | 2014-09-30 | 2020-03-11 | Allergan Industrie, SAS | Compositions d'hydrogel stables comprenant des additifs |
JP6656804B2 (ja) * | 2014-11-26 | 2020-03-04 | 小林製薬株式会社 | 外用組成物 |
WO2016128783A1 (fr) | 2015-02-09 | 2016-08-18 | Allergan Industrie Sas | Compositions et méthodes pour améliorer l'apparence de la peau |
FR3034989B1 (fr) * | 2015-04-20 | 2017-05-19 | Soc De Rech Cosmetique Sarl | Compositions cosmetiques comprenant des oligomeres d'acide hyaluronique et des cellules vegetales dedifferenciees et elicitees de bougainvillier encapsulant un extrait de safran |
Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0393904A2 (fr) * | 1989-04-17 | 1990-10-24 | Maxam, Inc. | Véhicule hydradant pour l'application topique de l'acide vitamine A |
WO1996010387A2 (fr) * | 1994-09-30 | 1996-04-11 | The Boots Company Plc | Composition pour stimulant capillaire |
WO1999062481A1 (fr) * | 1998-05-29 | 1999-12-09 | Guerlain S.A. | Procede de traitement cosmetique pour lutter contre les effets du vieillissement cutane |
US6024941A (en) * | 1992-07-13 | 2000-02-15 | Shiseido Company, Ltd. | External skin treatment composition |
KR20010001290A (ko) * | 1999-06-03 | 2001-01-05 | 서경배 | 피부 주름의 개선 및 생성 억제 효과를 갖는 외용제 조성물 |
EP1153601A1 (fr) * | 1999-02-17 | 2001-11-14 | Kabushiki Kaisha Yakult Honsha | Preparation pour la peau a usage externe |
WO2004000242A1 (fr) * | 2002-06-25 | 2003-12-31 | Cosmeceutic Solutions Pty Ltd | Compositions cosmetiques topiques |
WO2004056877A1 (fr) * | 2002-12-23 | 2004-07-08 | Sintofarm S.P.A. | Esters melanges d'acide hyaluronique comprenant des acides butyriques et hyaluroniques |
WO2005039532A1 (fr) * | 2003-10-17 | 2005-05-06 | Fidia Farmaceutici S.P.A. | Microemulsions de retinoide et compositions pharmaceutiques les contenant |
WO2007074288A1 (fr) * | 2005-12-21 | 2007-07-05 | Galderma Research & Development | Preparations pharmaceutiques ou cosmetiques pour application topique et/ou parenterale, leurs procedes de preparation, et leurs utilisations |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4439614A (en) * | 1982-09-22 | 1984-03-27 | Sri International | 5,6-Methano-5,6-dihydroretinoids |
US4879114A (en) * | 1985-12-20 | 1989-11-07 | Angio-Medical Corporation | Lipids from omentum and methods for cosmetic use |
US5723139A (en) * | 1996-09-27 | 1998-03-03 | Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. | Skin care compositions containing a polycyclic triterpene carboxylic acid and a retinoid |
WO2000038647A1 (fr) * | 1998-12-23 | 2000-07-06 | Esparma Gmbh | Agents pour proteger la peau, contenant un melange de fragments produit par hydrolyse a partir d'acide hyaluronique |
ITMI20020756A1 (it) * | 2002-04-09 | 2003-10-09 | Sinclair Pharma S R L | Composizioni farmaceutiche topiche per il trattamento delle dermatiti |
US7491709B2 (en) * | 2005-07-01 | 2009-02-17 | Wayne Carey | Treatment with hyaluronic acid |
-
2008
- 2008-04-22 EP EP08805683A patent/EP2155149A2/fr not_active Withdrawn
- 2008-04-22 WO PCT/FR2008/050728 patent/WO2008148967A2/fr active Application Filing
- 2008-04-22 CA CA002686558A patent/CA2686558A1/fr not_active Abandoned
- 2008-04-22 US US12/599,510 patent/US20100298259A1/en not_active Abandoned
Patent Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0393904A2 (fr) * | 1989-04-17 | 1990-10-24 | Maxam, Inc. | Véhicule hydradant pour l'application topique de l'acide vitamine A |
US6024941A (en) * | 1992-07-13 | 2000-02-15 | Shiseido Company, Ltd. | External skin treatment composition |
WO1996010387A2 (fr) * | 1994-09-30 | 1996-04-11 | The Boots Company Plc | Composition pour stimulant capillaire |
WO1999062481A1 (fr) * | 1998-05-29 | 1999-12-09 | Guerlain S.A. | Procede de traitement cosmetique pour lutter contre les effets du vieillissement cutane |
EP1153601A1 (fr) * | 1999-02-17 | 2001-11-14 | Kabushiki Kaisha Yakult Honsha | Preparation pour la peau a usage externe |
KR20010001290A (ko) * | 1999-06-03 | 2001-01-05 | 서경배 | 피부 주름의 개선 및 생성 억제 효과를 갖는 외용제 조성물 |
WO2004000242A1 (fr) * | 2002-06-25 | 2003-12-31 | Cosmeceutic Solutions Pty Ltd | Compositions cosmetiques topiques |
WO2004056877A1 (fr) * | 2002-12-23 | 2004-07-08 | Sintofarm S.P.A. | Esters melanges d'acide hyaluronique comprenant des acides butyriques et hyaluroniques |
WO2005039532A1 (fr) * | 2003-10-17 | 2005-05-06 | Fidia Farmaceutici S.P.A. | Microemulsions de retinoide et compositions pharmaceutiques les contenant |
WO2007074288A1 (fr) * | 2005-12-21 | 2007-07-05 | Galderma Research & Development | Preparations pharmaceutiques ou cosmetiques pour application topique et/ou parenterale, leurs procedes de preparation, et leurs utilisations |
Non-Patent Citations (1)
Title |
---|
DATABASE WPI Week 200146, Derwent World Patents Index; AN 2001-430654, XP002463330 * |
Cited By (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9265761B2 (en) | 2007-11-16 | 2016-02-23 | Allergan, Inc. | Compositions and methods for treating purpura |
US8853184B2 (en) | 2007-11-30 | 2014-10-07 | Allergan, Inc. | Polysaccharide gel formulation having increased longevity |
US9358322B2 (en) | 2008-08-04 | 2016-06-07 | Allergan Industrie Sas | Hyaluronic acid-based gels including lidocaine |
US9238013B2 (en) | 2008-08-04 | 2016-01-19 | Allergan Industrie, Sas | Hyaluronic acid-based gels including lidocaine |
US9228027B2 (en) | 2008-09-02 | 2016-01-05 | Allergan Holdings France S.A.S. | Threads of Hyaluronic acid and/or derivatives thereof, methods of making thereof and uses thereof |
US9333160B2 (en) | 2010-01-13 | 2016-05-10 | Allergan Industrie, Sas | Heat stable hyaluronic acid compositions for dermatological use |
US9114188B2 (en) | 2010-01-13 | 2015-08-25 | Allergan, Industrie, S.A.S. | Stable hydrogel compositions including additives |
US9125840B2 (en) | 2010-03-12 | 2015-09-08 | Allergan Industrie Sas | Methods for improving skin conditions |
US8921338B2 (en) | 2010-03-12 | 2014-12-30 | Allergan Industrie, Sas | Fluid compositions for improving skin conditions |
US9585821B2 (en) | 2010-03-12 | 2017-03-07 | Allergan Industrie Sas | Methods for making compositions for improving skin conditions |
US9012517B2 (en) | 2010-03-22 | 2015-04-21 | Allergan, Inc. | Polysaccharide and protein-polysaccharide cross-linked hydrogels for soft tissue augmentation |
US8691279B2 (en) | 2010-03-22 | 2014-04-08 | Allergan, Inc. | Polysaccharide and protein-polysaccharide cross-linked hydrogels for soft tissue augmentation |
US9393263B2 (en) | 2011-06-03 | 2016-07-19 | Allergan, Inc. | Dermal filler compositions including antioxidants |
US9408797B2 (en) | 2011-06-03 | 2016-08-09 | Allergan, Inc. | Dermal filler compositions for fine line treatment |
US11844878B2 (en) | 2011-09-06 | 2023-12-19 | Allergan, Inc. | Crosslinked hyaluronic acid-collagen gels for improving tissue graft viability and soft tissue augmentation |
Also Published As
Publication number | Publication date |
---|---|
WO2008148967A2 (fr) | 2008-12-11 |
EP2155149A2 (fr) | 2010-02-24 |
CA2686558A1 (fr) | 2008-12-11 |
US20100298259A1 (en) | 2010-11-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2008148967A3 (fr) | Preparations pharmaceutiques ou cosmetiques pour application topique et/ou parenterale, leurs procedes de preparation, et leurs utilisations | |
WO2008139122A3 (fr) | Preparations pharmaceutiques ou cosmetiques pour application topique et/ou parenterale, leurs procedes de preparation, et leurs utilisations | |
WO2008139123A3 (fr) | Preparations pharmaceutiques ou cosmetiques pour application topique et/ou parenterale, leurs procedes de preparation, et leurs utilisations | |
JP6386911B2 (ja) | 外用組成物 | |
EP1992645A4 (fr) | Nouvel acide hyaluronique a faible poids moleculaire et/ou sel de celui-ci, et preparation cosmetique, composition pharmaceutique et composition alimentaire chacune utilisant ledit acide | |
WO2009034559A3 (fr) | Procédé cosmétique pour un traitement esthétique et/ou de réparation de la peau | |
WO2008148966A3 (fr) | Preparations pharmaceutiques ou cosmetiques pour application topique et/ou parenterale, leurs procedes de preparation, et leurs utilisations | |
WO2007031883A3 (fr) | Composition contenant au moins un derive d'acide naphtoique et au moins un compose de type polymere de polyurethane ou des derives de ce compose, procedes de fabrication et utilisations de cette composition | |
JP5934164B2 (ja) | 外用組成物 | |
WO2009077693A3 (fr) | Compositions comprenant au moins un derive de l'acide naphtoique, du peroxyde de benzoyle et au moins un agent filmogene | |
JP2013173730A (ja) | 美白用組成物 | |
AU2015254602A1 (en) | Combination of a hyaluronic acid and of a sulphated polysaccharide | |
WO2008107092A3 (fr) | Utilisation de dérivés d'acide 4-hydroxyphénoxy acétique | |
WO2006013193A3 (fr) | Derives d'acide hydroxamique substitues par arylsulfonamido, utilises comme inhibiteurs des metalloproteinases matricielles | |
JP6262414B2 (ja) | 抗菌用組成物 | |
JP5931223B2 (ja) | 皮膚外用剤 | |
JP5951277B2 (ja) | アゼライン酸を含有する外用組成物 | |
WO2008152334A3 (fr) | Nouveaux dérivés d'acide 3-phenyl acrylique activateurs des récepteurs de type ppar, leur méthode de préparation et leur utilisation dans des compositions cosmétiques ou pharmaceutiques | |
MX2010000475A (es) | Hidrogel de carboxialquilamida de quitosano, su preparacion y sus usos cosmetico y dermatologico. | |
WO2008139124A3 (fr) | Preparations pharmaceutiques ou cosmetiques pour application topique et/ou parenterale, leurs procedes de preparation, et leurs utilisations | |
WO2006103119A3 (fr) | Nouveaux inhibiteurs de la tyrosinase, leur procede de preparation et leur utilisation dans des medicaments administrables aux hommes et aussi dans les cosmetiques | |
WO2008152260A3 (fr) | Nouveaux ligands agonistes des recepteurs rars, utilisation en medecine humaine ainsi qu'en cosmetique | |
PL2004235T3 (pl) | Kompozycja do zastosowania kosmetycznego lub farmaceutyczno-dermatologicznego | |
WO2012008457A1 (fr) | Composition pour application externe | |
WO2008152333A3 (fr) | Nouveaux dérivés d'acide 3-phényl propanoïque activateurs des récepteurs de type ppar, leur méthode de préparation et leur utilisation dans des compositions cosmétiques ou pharmaceutiques |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 08805683 Country of ref document: EP Kind code of ref document: A2 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2008805683 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2686558 Country of ref document: CA |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 12599510 Country of ref document: US |